Great Point Partners as of June 30, 2016
Portfolio Holdings for Great Point Partners
Great Point Partners holds 39 positions in its portfolio as reported in the June 2016 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Adamas Pharmaceuticals | 9.1 | $32M | 2.1M | 15.14 | |
| Vanda Pharmaceuticals (VNDA) | 8.7 | $30M | 2.7M | 11.19 | |
| Synergy Pharmaceuticals | 8.3 | $29M | 7.6M | 3.80 | |
| Exelixis (EXEL) | 7.2 | $25M | 3.2M | 7.81 | |
| Dermira | 6.7 | $23M | 800k | 29.25 | |
| Bluebird Bio (BLUE) | 6.2 | $22M | 500k | 43.29 | |
| Neurocrine Biosciences (NBIX) | 6.1 | $21M | 470k | 45.45 | |
| Eagle Pharmaceuticals (EGRX) | 6.1 | $21M | 548k | 38.79 | |
| Zogenix | 5.6 | $20M | 2.4M | 8.05 | |
| Ignyta | 5.0 | $18M | 3.2M | 5.42 | |
| Enanta Pharmaceuticals (ENTA) | 3.4 | $12M | 538k | 22.05 | |
| Sage Therapeutics (SAGE) | 2.9 | $9.9M | 330k | 30.13 | |
| Tetraphase Pharmaceuticals | 2.8 | $9.9M | 2.3M | 4.30 | |
| Connecture | 2.7 | $9.3M | 4.1M | 2.26 | |
| Xencor (XNCR) | 2.5 | $8.5M | 450k | 18.99 | |
| Aurinia Pharmaceuticals (AUPH) | 2.1 | $7.2M | 2.5M | 2.93 | |
| Alcobra | 1.8 | $6.4M | 1.4M | 4.49 | |
| Raptor Pharmaceutical | 1.5 | $5.3M | 978k | 5.37 | |
| Sarepta Therapeutics (SRPT) | 1.3 | $4.6M | 239k | 19.07 | |
| Sunesis Pharmaceuticals | 1.3 | $4.5M | 8.2M | 0.55 | |
| Bovie Medical Corporation | 1.3 | $4.4M | 2.7M | 1.64 | |
| Aradigm | 1.2 | $4.4M | 1.0M | 4.37 | |
| Intra Cellular Therapies (ITCI) | 1.1 | $3.9M | 100k | 38.82 | |
| Ocera Therapeutics | 1.1 | $3.7M | 2.0M | 1.90 | |
| Seres Therapeutics (MCRB) | 1.0 | $3.5M | 120k | 29.05 | |
| Tenax Therapeutics | 0.8 | $2.8M | 1.1M | 2.56 | |
| Foamix Pharmaceuticals | 0.5 | $1.7M | 275k | 6.35 | |
| Adverum Biotechnologies | 0.5 | $1.7M | 550k | 3.16 | |
| Ascendis Pharma A S (ASND) | 0.3 | $1.0M | 77k | 13.27 | |
| Caladrius Biosciences | 0.3 | $900k | 1.5M | 0.59 | |
| Dipexium Pharmaceuticals | 0.2 | $871k | 88k | 9.91 | |
| Vericel (VCEL) | 0.2 | $570k | 254k | 2.25 | |
| Paratek Pharmaceuticals | 0.1 | $407k | 29k | 13.91 | |
| Axovant Sciences | 0.1 | $321k | 25k | 12.84 | |
| Revance Therapeutics (RVNC) | 0.1 | $295k | 22k | 13.62 | |
| Streamline Health Solutions (STRM) | 0.1 | $182k | 152k | 1.20 | |
| Rigel Pharmaceuticals (RIGL) | 0.0 | $112k | 50k | 2.24 | |
| Ardelyx (ARDX) | 0.0 | $30k | 3.4k | 8.71 | |
| Amarin Corporation (AMRN) | 0.0 | $4.0k | 2.0k | 2.00 |
